Molecular mechanisms of cholinergic neurotransmission in visceral smooth muscles with a focus on receptor-operated TRPC4 channel and impairment of gastrointestinal motility by general anaesthetics and anxiolytics.
Anti-Anxiety Agents
/ pharmacology
Acetylcholine
/ metabolism
Muscle, Smooth
Receptors, Muscarinic
/ metabolism
Ion Channels
/ metabolism
Muscle Contraction
Synaptic Transmission
Anesthetics, General
/ pharmacology
Cholinergic Agents
/ pharmacology
Gastrointestinal Motility
Receptor, Muscarinic M3
/ agonists
Acetylcholine
Anxiolytics
Gastrointestinal smooth muscle
General anaesthetics
Muscarinic receptor
TRPC4
Journal
Neuropharmacology
ISSN: 1873-7064
Titre abrégé: Neuropharmacology
Pays: England
ID NLM: 0236217
Informations de publication
Date de publication:
01 Jan 2024
01 Jan 2024
Historique:
received:
08
08
2023
revised:
13
10
2023
accepted:
23
10
2023
medline:
24
11
2023
pubmed:
2
11
2023
entrez:
1
11
2023
Statut:
ppublish
Résumé
Acetylcholine is the primary excitatory neurotransmitter in visceral smooth muscles, wherein it binds to and activates two muscarinic receptors subtypes, M
Identifiants
pubmed: 37913983
pii: S0028-3908(23)00366-0
doi: 10.1016/j.neuropharm.2023.109776
pii:
doi:
Substances chimiques
Anti-Anxiety Agents
0
Acetylcholine
N9YNS0M02X
Receptors, Muscarinic
0
Ion Channels
0
Anesthetics, General
0
Cholinergic Agents
0
Receptor, Muscarinic M3
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
109776Informations de copyright
Copyright © 2023 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.